|
Other links at Biotechnology and Pharmaceuticals > Pharmaceuticals > Cancer > Research and Development |
| 1. |
ImmunoGen, Inc.
|
|
|
Licenses tumor-activated prodrug technology, for development of small molecule anticancer agents, to optimise potency and toxicity. Manufacturing in Norwood, and headquarters in Cambridge, Massachusetts. (Nasdaq: IMGN)
|
| 2. |
Genaera Corp.
|
|
|
Develops drugs for asthma, cancer, cystic fibrosis and age-related macular degeneration. Includes overview of clinical trials, investor information and news from company in Plymouth Meeting, Pennsylvania. (Nasdaq: GENR)
|
| 3. |
ARIAD Pharmaceuticals, Inc.
|
|
|
Develops drugs which block intracellular signal transduction pathways for treating solid tumors and hematologic malignancies. Includes kits available, technology overview and investor data from Cambridge, Massachusetts. (Nasdaq: ARIA)
|
| 4. |
Onyx Pharmaceuticals, Inc.
|
|
|
Discovers and develops small molecule therapeutics based upon the genetics of human disease, with emphasis on cell growth inhibitors. Includes clinical pipeline, technology overview and investor relations at Richmond, California. (Nasdaq: ONXX)
|
| 5. |
Panacea Pharmaceuticals, Inc.
|
|
|
Focused on utilizing functional genomics and proteomics to develop therapeutic agents and diagnostic tests for diseases with substantial unmet clinical need.
|
|
|
Add to My Favorite
Refer it to Friend
Report Broken Link
